Encompass Health to present at UBS Global Healthcare Conference
Get Alerts EHC Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.7%
Revenue Growth %: +7.5%
Join SI Premium – FREE
BIRMINGHAM, Ala., May 12, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will present at the UBS Global Healthcare Conference being held May 23-25, 2022 in New York City.
Encompass Health's President and Chief Executive Officer Mark Tarr and Executive Vice President and Chief Financial Officer Doug Coltharp will participate in a fireside chat from 9:15-9:55 a.m. ET on Tuesday, May 24, 2022.
The presentation will be webcast live and available at http://investor.encompasshealth.com.
About Encompass Health As a national leader in integrated healthcare services, Encompass Health (NYSE: EHC) offers both facility–based and home–based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that includes 148 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico, the Company provides high–quality, cost-effective integrated healthcare. Encompass Health is ranked as one of Fortune's 100 Best Companies to Work For. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter, Instagram and Facebook.
Media ContactErin Wendel-Ritter | 205 970-5912[email protected]
Investor Relations ContactMark Miller | 205 970-5860[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-to-present-at-ubs-global-healthcare-conference-301546366.html
SOURCE Encompass Health Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- STARTRADER Hosts KTH Alumni Evening in Dubai, Connecting AI, Technology, and Innovation Leaders
- AXIA Time Makes FIFA World Cup 2026™ Official Licensed Product Collection More Accessible with New Fan Shopping Experience and World Champion Guarantee
- Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
UBS, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share